Compare BCML & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCML | XBIT |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.3M | 73.2M |
| IPO Year | N/A | 2015 |
| Metric | BCML | XBIT |
|---|---|---|
| Price | $33.12 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 19.8K | ★ 66.1K |
| Earning Date | 01-22-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $94,896,000.00 | N/A |
| Revenue This Year | $0.51 | N/A |
| Revenue Next Year | $10.33 | N/A |
| P/E Ratio | $15.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.22 | $2.09 |
| 52 Week High | $33.12 | $6.92 |
| Indicator | BCML | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 75.29 | 53.60 |
| Support Level | $27.94 | $2.41 |
| Resistance Level | $32.98 | $2.59 |
| Average True Range (ATR) | 0.88 | 0.15 |
| MACD | 0.32 | 0.01 |
| Stochastic Oscillator | 96.35 | 66.67 |
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.